BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sicard G, Fina F, Fanciullino R, Barlesi F, Ciccolini J. Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy. Pharmaceutics 2020;12:E758. [PMID: 32796670 DOI: 10.3390/pharmaceutics12080758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Le Louedec F, Leenhardt F, Marin C, Chatelut É, Evrard A, Ciccolini J. Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective. Vaccines (Basel) 2020;8:E632. [PMID: 33142728 DOI: 10.3390/vaccines8040632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Qureshi S, Chan N, George M, Ganesan S, Toppmeyer D, Omene C. Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker. Biomark�Insights 2022;17:117727192210787. [DOI: 10.1177/11772719221078774] [Reference Citation Analysis]
3 Bousbaa H. Novel Anticancer Strategies. Pharmaceutics 2021;13:275. [PMID: 33670469 DOI: 10.3390/pharmaceutics13020275] [Reference Citation Analysis]
4 Mogenet A, Greillier L, Tomasini P. The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung Cancer. Pharmgenomics Pers Med 2021;14:987-96. [PMID: 34429632 DOI: 10.2147/PGPM.S267437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]